Search research articles
Contact Us
Filters
Showing results (1-10 of 46) with videos related to
Page
of 5
Sort By:
Survey of Ophthalmology
|
March 16, 2004
A cost-effectiveness comparison of bimatoprost versus latanoprost in patients with glaucoma or ocular hypertension
John G Walt, Jeffrey T Lee
Journal of Glaucoma
|
May 1, 2004
Trends in glaucoma surgery before and after the introduction of new topical glaucoma pharmacotherapies
David R Strutton, John G Walt
American Journal of Ophthalmology
|
January 4, 2006
Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications
Robert J Noecker, John G Walt
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
April 14, 2010
Safety, effectiveness, and subjective experience with topical bimatoprost 0.03% for eyelash growth
Steve Yoelin, John G Walt, Melissa Earl
Journal of Glaucoma
|
June 26, 2010
Psychometric evaluation of the Glaucoma Symptom Identifier
John G Walt, Regina Rendas-Baum, Mark Kosinski, et al.
The American Journal of Managed Care
|
March 20, 2008
Disease progression and the need for neuroprotection in glaucoma management
Rohit Varma, Patti Peeples, John G Walt, et al.
Journal of Glaucoma
|
June 16, 2009
The relationship of mean deviation scores and resource utilization among patients with glaucoma: a retrospective United States and European chart review analysis
Karina Berenson, Steven Kymes, John G Walt, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
October 20, 2010
Paired-eye comparison of medical therapies for glaucoma
Alfred M Solish, Friedericke James, John G Walt, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
January 24, 2007
Efficiency of instillation methods for prostaglandin medications
Richard Fiscella, Jacob T Wilensky, Tina H Chiang, et al.
BMC Ophthalmology
|
June 13, 2008
Comparative study of the stability of bimatoprost 0.03% and latanoprost 0.005%: a patient-use study
Mauricio D Paolera, Niro Kasahara, Cristiano C Umbelino, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 46) with videos related to
Sort By:
Page
of 5
Survey of Ophthalmology
|
March 16, 2004
A cost-effectiveness comparison of bimatoprost versus latanoprost in patients with glaucoma or ocular hypertension
John G Walt, Jeffrey T Lee
Journal of Glaucoma
|
May 1, 2004
Trends in glaucoma surgery before and after the introduction of new topical glaucoma pharmacotherapies
David R Strutton, John G Walt
American Journal of Ophthalmology
|
January 4, 2006
Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications
Robert J Noecker, John G Walt
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
April 14, 2010
Safety, effectiveness, and subjective experience with topical bimatoprost 0.03% for eyelash growth
Steve Yoelin, John G Walt, Melissa Earl
Journal of Glaucoma
|
June 26, 2010
Psychometric evaluation of the Glaucoma Symptom Identifier
John G Walt, Regina Rendas-Baum, Mark Kosinski, et al.
The American Journal of Managed Care
|
March 20, 2008
Disease progression and the need for neuroprotection in glaucoma management
Rohit Varma, Patti Peeples, John G Walt, et al.
Journal of Glaucoma
|
June 16, 2009
The relationship of mean deviation scores and resource utilization among patients with glaucoma: a retrospective United States and European chart review analysis
Karina Berenson, Steven Kymes, John G Walt, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
October 20, 2010
Paired-eye comparison of medical therapies for glaucoma
Alfred M Solish, Friedericke James, John G Walt, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
January 24, 2007
Efficiency of instillation methods for prostaglandin medications
Richard Fiscella, Jacob T Wilensky, Tina H Chiang, et al.
BMC Ophthalmology
|
June 13, 2008
Comparative study of the stability of bimatoprost 0.03% and latanoprost 0.005%: a patient-use study
Mauricio D Paolera, Niro Kasahara, Cristiano C Umbelino, et al.
Page
of 5